Olema Oncology to Participate in Upcoming Investor Conferences
Alpha Vantage · Quiver Quantitative · · AI-summarised by FinFlash
Olema Oncology, a biopharmaceutical company focused on breast cancer therapies, announced its participation in three upcoming investor conferences: the Evercore Healthcare Conference on November 30, 2026, the Citi Global Healthcare Conference on December 1, 2026, and the Piper Sandler Healthcare Conference on December 2, 2026.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.